Logo

Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

Share this
Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

Province Expands the Use of Biosimilars to Improve the Sustainability of Public Drug Plans

Shots:

  • The provincial government is improving the sustainability of its public drug plans by expanding the use of biosimilars
  • This initiative follows similar policies implemented by British Columbia and Alberta over the past 2yrs.- where 10-000 of patients in each province were safely switched from an originator biologic drug to a biosimilar
  • The initiative allows the government to fund new drugs as switching to biosimilar results in savings. The province’s plans to provide subsidized drug coverage for about 135-000 people while in 2019-20- the province invested about $220M in these drug plans

  Ref: Biosimilars | Image: Twitter

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Related News/Articles

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions